« Zurück
Startseite /
Recombinant Transforming Growth Factor Beta 1 (TGFb1)

Recombinant Transforming Growth Factor Beta 1 (TGFb1)

ArtNr	RPA124Ra01-10ug
Hersteller	Cloud-Clone
Menge	10 ug
Quantity options	100 ug 10 ug 1 mg 200 ug 500 ug 50 ug
Kategorie	Oncology Peptides & Proteins Recombinant Proteins By Organ Colorectal Cancer
Typ	Proteins
Applikationen	WB, SDS-PAGE, other
Specific against	Rat (Rattus norvegicus)
Host	E.coli
Konjugat/Tag	HIS
Purity	> 90%
Sequence	Ala279ca.Ser390
Citations	Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effectsPeriostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: reduction of PPARαRed Nucleus Interleukin-6 Evokes Tactile Allodynia in Male Rats Through Modulating Spinal Pro-inflammatory and Anti-inflammatory Cytokines
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	TGF-B1; CED; DPD1; LAP; Camurati-Engelmann Disease; Latency-associated peptide
Similar products	Latency-associated peptide, LAP, CED, DPD1, TGF-B1, Camurati-Engelmann Disease
Lieferbar
Sequence	Ala279ca.Ser390
Predicted Molecular Mass(KD)	14.1kDa
Accurate Molecular Mass(KD)	16kDa
Purity	> 90%
Uniprot Link	P17246
Subcellular location	Secreted, Extracellular matrix
Isoelectric Point	8, 4
Item Name	Transforming Growth Factor Beta 1
Alternative Names	TGF-B1, CED, DPD1, LAP, Camurati-Engelmann Disease, Latency-associated peptide
Buffer	PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Traits	Freeze-dried powder
Tag	N-terminal His Tag
Research Area	Cytokine; Tumor immunity; Infection immunity;
Expression System	Prokaryotic expression
Appilcaiton info	Positive Control, Immunogen, SDS-PAGE, WB.
Citation	Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: reduction of PPAR?

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.